Out-Licensing
The company’s internationalization is, nowadays, a reality, with several products from Tecnifar’s portfolio, sold in countries such as:
- Reino Unido
- UK
- Malta
- Angola
- Mozambique
- Cape Green
- Nigeria
- UAE
- Iran
- Panama
Our strategy contemplates the future launch of our own products, in several territories, through partnerships with local companies, supported by export, licensing, representation and distribution contracts, in Europe, America, Asia and Africa.
Through a licensing agreement with a local company (Consilient Health), and with a specific brand for this market (Belvo®), Tecnifar has achieved relevant performance in the area of bipolar disease, positively impacting the lives of thousands of patients, in the United Kingdom.
Tecnifar is currently involved in new out-licensing projects, with licensing agreements signed and registration processes underway, in territories such as:
- South Africa
- Saudi Arabia
- Vietnam
- Croatia
- Slovenia
- Serbia
- Greece
- UAE
- Netherlands
Our dossiers are available in e-CTD format and able to adapt to local requirements.
In-Licensing
Tecnifar’s operations in Portuguese territory are divided between the marketing and distribution of its own medicines, and the launch of patented medicines by international companies of recognized competence, such as: Almirall, Angelini, Desitin, Ferring, Menarini, Neuraxpharm, Teva, Medinfar and Uriach, among others.
We offer our partners an added value proposition and a complete approach, in which we make our marketing/sales/distribution structures and regulatory & scientific affairs available, for the benefit of the projects in which we are involved.
Our main areas of activity are: Central Nervous System, Cardiovascular, Respiratory, Urology and Osteoarticular.